Sequence variants of estrogen receptor beta and risk of prostate cancer in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium.

Sequence variants of estrogen receptor beta and risk of prostate cancer in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium.

BACKGROUND: Estrogen receptor beta (ESR2) may play a role in modulating prostate carcinogenesis through the regulation of genes related to cell proliferation and apoptosis. METHODS: We conducted nested case-control studies in the Breast and Prostate Cancer Cohort Consortium (BPC3) that pooled 8,323...

Full description

Bibliographic Details
Main Authors: Chen, Y, Kraft, P, Bretsky, P, Ketkar, S, Hunter, D, Albanes, D, Altshuler, D, Andriole, G, Berg, C, Boeing, H, Burtt, N, Bueno-de-Mesquita, B, Cann, H, Canzian, F, Chanock, S, Dunning, A, Feigelson, H, Freedman, M, Gaziano, J, Giovannucci, E, Sánchez, M, Haiman, C, Hallmans, G, Hayes, R, Henderson, B
Format: Journal article
Language:English
Published: 2007

Similar Items